DK0717041T3 - Krystallinske paclitaxel-hydrater - Google Patents

Krystallinske paclitaxel-hydrater

Info

Publication number
DK0717041T3
DK0717041T3 DK95119595T DK95119595T DK0717041T3 DK 0717041 T3 DK0717041 T3 DK 0717041T3 DK 95119595 T DK95119595 T DK 95119595T DK 95119595 T DK95119595 T DK 95119595T DK 0717041 T3 DK0717041 T3 DK 0717041T3
Authority
DK
Denmark
Prior art keywords
hydrates
crystalline paclitaxel
paclitaxel
pseudopolymorph
crystalline
Prior art date
Application number
DK95119595T
Other languages
Danish (da)
English (en)
Inventor
Scott R Stenberg
Akram Saab
Shreeram Agharkar
Robert K Perrone
Murray A Kaplan
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23396320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0717041(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0717041T3 publication Critical patent/DK0717041T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK95119595T 1994-12-13 1995-12-12 Krystallinske paclitaxel-hydrater DK0717041T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35512594A 1994-12-13 1994-12-13

Publications (1)

Publication Number Publication Date
DK0717041T3 true DK0717041T3 (da) 2002-11-25

Family

ID=23396320

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95119595T DK0717041T3 (da) 1994-12-13 1995-12-12 Krystallinske paclitaxel-hydrater

Country Status (9)

Country Link
EP (1) EP0717041B2 (pt)
JP (1) JPH08208636A (pt)
AT (1) ATE221879T1 (pt)
AU (1) AU699542B2 (pt)
CA (1) CA2163837C (pt)
DE (1) DE69527696T3 (pt)
DK (1) DK0717041T3 (pt)
ES (1) ES2181744T5 (pt)
PT (1) PT717041E (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
FR2729666A1 (fr) * 1995-01-25 1996-07-26 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r, 3s)- benzoylamino-2-hydroxy-3-phenylpropionate de 4,10-diacetoxy- 2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxo- tax-11-en-13alpha-yle
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
WO1998043618A2 (en) † 1997-03-31 1998-10-08 Neorx Corporation Use of cytoskeletal inhibitors for the prevention of restenosis
HUP9701945A3 (en) * 1997-11-10 2000-04-28 Hexal Ag Pharmaceutical composition for injection containing cyclodextrin and taxoids
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
PL203300B1 (pl) * 2000-10-31 2009-09-30 Akad Medyczna Stabilna postać farmaceutyczna leku przeciwnowotworowego oraz sposób wytwarzania stabilnej postaci farmaceutycznej leku przeciwnowotworowego
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
KR20050044621A (ko) 2001-11-30 2005-05-12 브리스톨-마이어스 스큅 컴퍼니 파클리탁셀 용매화물
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
US7919108B2 (en) 2006-03-10 2011-04-05 Cook Incorporated Taxane coatings for implantable medical devices
US7875284B2 (en) 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
EP2380606B1 (en) 2006-06-30 2018-03-21 Cook Medical Technologies LLC Methods of manufacturing and modifying taxane coatings for implantable medical devices
CA2673991C (en) 2007-01-21 2012-02-07 Hemoteq Ag Methods for coating catheter balloons with a defined quantity of active agent
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
US10369256B2 (en) 2009-07-10 2019-08-06 Boston Scientific Scimed, Inc. Use of nanocrystals for drug delivery from a balloon
US10080821B2 (en) 2009-07-17 2018-09-25 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
WO2012031236A1 (en) 2010-09-02 2012-03-08 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
WO2013022458A1 (en) 2011-08-05 2013-02-14 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
WO2013028208A1 (en) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
WO2015123082A1 (en) * 2014-02-14 2015-08-20 Boston Scientific Scimed, Inc. Rapidly degrading embolic particles with therapeutic agent release

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) † 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4960790A (en) † 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5380916A (en) † 1990-11-02 1995-01-10 University Of Florida Method for the isolation and purification of taxane derivatives
TW467896B (en) † 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes

Also Published As

Publication number Publication date
ATE221879T1 (de) 2002-08-15
PT717041E (pt) 2002-11-29
CA2163837C (en) 1999-07-20
DE69527696T2 (de) 2003-04-03
AU4035595A (en) 1996-06-20
EP0717041B2 (en) 2007-08-15
AU699542B2 (en) 1998-12-03
ES2181744T5 (es) 2008-03-01
DE69527696D1 (de) 2002-09-12
JPH08208636A (ja) 1996-08-13
EP0717041B1 (en) 2002-08-07
CA2163837A1 (en) 1996-06-14
DE69527696T3 (de) 2008-04-03
EP0717041A1 (en) 1996-06-19
ES2181744T3 (es) 2003-03-01

Similar Documents

Publication Publication Date Title
DK0717041T3 (da) Krystallinske paclitaxel-hydrater
NO943002D0 (no) Fosfono-oksymetyletere av taxanderivater
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
HK1040721A1 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
DK0607389T3 (da) Bearbejdelige, cementbaserede sammensætninger
CA2152771A1 (en) 7-o-ethers of taxane derivatives
SE9801494D0 (sv) Novel use
DE4493718T1 (de) Abbaubare Succinsäurederivatchelanten, Verwendungen und Zusammensetzungen davon
FI945439A (fi) Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät koostumukset
DK1073447T3 (da) N1-modificerede glycopeptider
DE60029084D1 (de) Neue depsipeptid-verbindung
DE69513889T2 (de) Degradierbare Mischungszusammensetzung
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto
BR9902081A (pt) Combinação de dofetilida e um bloqueador dos canais de cálcio
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents